overview

drivers

utilities

transport

finance

media

chemicals

metals

food

auto/aero

property

infrastructure

engineering

retail

hospitality

packaging

clothing

ICT

advertising

accounting

tobacco

pharma

+ studies

collapses










































related
Profiles
& Notes:

telecoms
bubble

Aust & NZ
telecoms

telco
privatisations

telco
mergers &
acquisitions

IPOs

Private
Equity
Funds

Hedge
Funds

Collectibles,
Prices,
Cultures

     pharmaceuticals and health services (studies)

This page supplements the note on benchmarks in the pharmaceuticals, medical devices and health service sectors, highlighting literature on those industries.

It covers -

• overviews
• corporate histories

     overviews

Points of entry to the literature include Shaping the Industrial Century: The Remarkable Story of the Evolution of the Modern Chemical and Pharmaceutical Industries (Cambridge: Harvard Uni Press 2005) by Alfred Chandler, Medical Science and Medical Industry: The Formation of the American Pharmaceutical Industry (Baltimore: Johns Hopkins Uni Press 1987) by Jonathan Liebenau, The Law and Ethics of the Pharmaceutical Industry (London: Elsevier 2006) by Graham Dukes, Knowledge Accumulation and Industry Evolution: The Case of Pharma-Biotech (Cambridge: Cambridge Uni Press 2006) edited by Mariana Mazzucato & Giovanni Dosi, Intellectual Property Rights and the Life Sciences Industries: A Twentieth Century History (Aldershot: Ashgate 2003) by Graham Dutfield and The First Miracle Drugs: How the Sulfa Drugs Transformed Medicine (New York: Oxford Uni Press 2007) by John Lesch.

Criticisms include The Truth About the Drug Companies: How They Deceive Us and What To Do About It (New York: Random House) by Marcia Angell, The Big Fix: How the Pharmaceutical Industry Rips Off American Consumers (New York: Public Affairs) by Katharine Greider, On the Take: How Medicine’s Complicity with Big Business Can Endanger Your Health (Oxford: Oxford Uni Press ) by Jerome Kassirer and Big Pharma: Exposing the Global Healthcare Agenda (New York: Carroll & Graf) by Jacky Law.

     corporate histories

Corporate histories and criticisms include Networks of Innovation: Vaccine Development at Merck, Sharp & Dohme, and Mulford, 1895-1995 (Cambridge: Cambridge Uni Press 1995) by Louis Galambos & Jane Sewell, The Merck Druggernaut: The Inside Story Of A Pharmaceutical Giant (New York: Wiley 2005) by Fran Hawthorne and Medicine, Science & Merck (Cambridge: Cambridge Uni Press 2005) by Roy Vagelos & Louis Galambos, The Business of Medicine: The Extraordinary History of Glaxo, a Baby Food Producer, Which Became One of the World's Most Successful Pharmaceutical Companies (London: Profile Books 2001) by Edgar Jones and Glaxo: A History to 1962 (Cambridge: Cambridge Uni Press 1992) by Richard Davenport-Hines & Judy Slinn, National Cultures and International Competition: The Experience of Schering AG, 1851-1950 (Cambridge: Cambridge Uni Press 2002) by Christopher Kobrak, Wealth of Contrasts: Nyegaard & Co - A Norwegian Pharmaceutical Company, 1874-1985 (Oslo: Gyldendal 1998) by Rolv Amdam & Knut Sogner, A History of May & Baker (Cambridge: Hobsons 1984) and Pharmaceutical and Health Care: A history of Abbott Laboratories in the UK (Cambridge: Granta 1999) by Judy Slinn,

   next page (collapses)